Medical Pharmaceuticals All the latest pharmaceutical news, including the research and development of new medications and treatments. This section contains releases regarding clinical trials at all stages, FDA approval status, and general pharmaceutical research results. Find storing relating to the release and marketing of new drugs alongside corporate and financial reporting from pharmaceutical companies, including stock and shareholder information, annual meetings, board changes and appointments, quarterly reports, and new acquisitions and mergers.

11:12 ET
Call to Action Summit 2015
11:00 ET
10:25 ET
Race car driver Danica Patrick will focus on disease prevention and health screenings in an advertising campaign that's part of the next phase of Edward-Elmhurst Healthcare's "Healthy Driven" initiative
09:30 ET
09:16 ET
09:00 ET
08:31 ET
08:30 ET
08:14 ET
Perrigo Company
08:03 ET
Recondo's cloud-based solutions deliver financial clarity to all participants within the healthcare revenue cycle. Recondo empowers more than 850 hospitals with solutions that connect providers, payers and patients to ensure proper payments across the care continuum. The company's software and expertise streamline operations and bring efficiencies and cost savings to patient access through to payment processing-a continuum today where inaccuracy and inefficiencies currently cost U.S. healthcare a staggering $480 billion per year. Visit us at www.recondotech.com.
08:03 ET
Perrigo Company.
07:21 ET
07:00 ET
The MagVita TMS Therapy system from MagVenture which is here seen, has of July 31 2015 been cleared by the US Food and Drug Administration for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. (PRNewsFoto/MagVenture)
06:00 ET
06:00 ET
Specialdocs Logo.
05:32 ET
04:30 ET
Grand View Research Logo
04:00 ET
Volcano iFR Scout(TM): pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions (PRNewsFoto/Royal Philips)
04:00 ET
Volcano iFR Scout(TM): pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions (PRNewsFoto/Royal Philips)
04:00 ET
Volcano iFR Scout(TM): pullback technology that reveals the physiologic profile of the entire vessel and is optimized to assess serial lesions and diffuse coronary disease enabling physicians to make informed treatment decisions (PRNewsFoto/Royal Philips)

Jump to news releases